...
首页> 外文期刊>Therapeutic advances in drug safety. >Predicting risk of adverse drug reactions in older adults
【24h】

Predicting risk of adverse drug reactions in older adults

机译:预测老年人药物不良反应的风险

获取原文
           

摘要

Adverse drug reactions (ADRs) are common in older adults, with falls, orthostatic hypotension, delirium, renal failure, gastrointestinal and intracranial bleeding being amongst the most common clinical manifestations. ADR risk increases with age-related changes in pharmacokinetics and pharmacodynamics, increasing burden of comorbidity, polypharmacy, inappropriate prescribing and suboptimal monitoring of drugs. ADRs are a preventable cause of harm to patients and an unnecessary waste of healthcare resources. Several ADR risk tools exist but none has sufficient predictive value for clinical practice. Good clinical practice for detecting and predicting ADRs in vulnerable patients includes detailed documentation and regular review of prescribed and over-the-counter medications through standardized medication reconciliation. New medications should be prescribed cautiously with clear therapeutic goals and recognition of the impact a drug can have on multiple organ systems. Prescribers should regularly review medication efficacy and be vigilant for ADRs and their contributory risk factors. Deprescribing should occur at an individual level when drugs are no longer efficacious or beneficial or when safer alternatives exist. Inappropriate prescribing and unnecessary polypharmacy should be minimized. Comprehensive geriatric assessment and the use of explicit prescribing criteria can be useful in this regard.
机译:药物不良反应(ADR)在老年人中很常见,跌倒,体位性低血压,del妄,肾功能衰竭,胃肠道和颅内出血是最常见的临床表现。随着年龄的变化,药代动力学和药效学变化,合并症,多重药房,不适当的处方药和药物监测不佳的负担,ADR风险会增加。 ADR是可预防的对患者造成伤害的原因,是不必要地浪费医疗资源的原因。存在几种ADR风险工具,但没有一个对临床实践具有足够的预测价值。在易受伤害的患者中检测和预测ADR的良好临床实践包括详细的文档记录,以及通过标准化药物对账定期检查处方药和非处方药。应谨慎地开具新药,明确治疗目标,并认识到药物可能对多个器官系统产生的影响。处方者应定期检查药物疗效,并注意ADR及其相关危险因素。当药物不再有效或不再有益或存在更安全的替代药物时,应在个人层面上取消处方。应尽量减少不适当的处方和不必要的多元药房。在这方面,全面的老年医学评估和使用明确的处方标准可能会有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号